Test Bank:
2i
Advanced Pharmacology for Prescribers 1st Edition Luu Kayingo Latest
2i 2i 2i 2i 2i 2i 2i 2i 2i
Edition, 2024
2i
, Table of Contents 2i 2i
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines ............................................ 3
2i 2i 2i 2i 2i 2i 2i 2i
Chapter 2: Pharmacokinetics /Chapter3: Pharmacodynamics ................................................................... 13
2i 2i 2i 2i
Chapter4: Pharmacogenetics and Pharmacogenomics................................................................................ 25
2i 2i 2i
Chapter 5: Pharmacology Across the Life Span ........................................................................................ 30
2i 2i 2i 2i 2i 2i
Chapter 6: Drug-Therapy Prescribing in Special Populations ................................................................... 36
2i 2i 2i 2i 2i 2i
Chapter 7: Drug Development and Approval ............................................................................................ 45
2i 2i 2i 2i 2i
Chapter 8-Chapter 10: Foundations of Prescription Writing Chapter 9: ResponsibleControlled-
2i 2i 2i 2i 2i 2i 2i 2i 2i
Substance Prescribing Chapter 10: Antibiotic Stewardship ........................................................................ 51
2i 2i 2i 2i 2i
Chapter 11: Applied Calculations for Prescribing ..................................................................................... 58
2i 2i 2i 2i 2i
Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-
2i 2i 2i 2i 2i 2i 2i 2i 2i
Focused Prescribing Chapter 13: Pharmacotherapy for Ear, Nose, Mouth, andThroat Conditions /Chapter
2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2
14: Pharmacotherapy for Eye Conditions ................................................................................................... 67
i 2i 2i 2i 2i
Chapter 15: Pharmacotherapy for Skin Conditions ................................................................................... 74
2i 2i 2i 2i 2i
Chapter 16: Pharmacotherapy for Neurologic Conditions ........................................................................ 81
2i 2i 2i 2i 2i
Chapter 17: Pharmacotherapy for Cardiovascular Conditions.................................................................. 94
2i 2i 2i 2i 2i
Chapter 18: Pharmacotherapy for Respiratory Conditions ..................................................................... 106
2i 2i 2i 2i 2i
Chapter 19: Pharmacotherapy for Gastrointestinal Conditions and Conditions RequiringNutritional Suppo
2i 2i 2i 2i 2i 2i 2i 2i 2i
rt ................................................................................................................................................................ 117
Chapter 20: Pharmacotherapy for Genitourinary Conditions .................................................................. 128
2i 2i 2i 2i 2i
Chapter 21: Pharmacotherapy for Renal, Acid–Base, Fluid, and Electrolyte Disorders ........................ 133
2i 2i 2i 2i 2i 2i 2i 2i 2i
Chapter 22: Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions ............................. 146
2i 2i 2i 2i 2i 2i 2i
Chapter 23: Therapeutic Applications of Immunology and Vaccines ................................................... 158
2i 2i 2i 2i 2i 2i 2i
Chapter 24: Pharmacotherapy for Endocrine Disorders .......................................................................... 163
2i 2i 2i 2i 2i
Chapter 25: Pharmacotherapy for Hematologic Disorders ...................................................................... 174
2i 2i 2i 2i 2i
Chapter 26: Hematology/Oncology and Supportive Care for the Nononcologist .................................. 190
2i 2i 2i 2i 2i 2i 2i 2i
Chapter 27: Pharmacotherapy Related to Women’s Health Conditions ................................................ 196
2i 2i 2i 2i 2i 2i 2i
Chapter 28: Pharmacotherapy Related to Men’s Health Conditions ...................................................... 211
2i 2i 2i 2i 2i 2i 2i
Chapter 29: Pharmacotherapy Related to Transgender Care .................................................................. 217
2i 2i 2i 2i 2i 2i
Chapter 30: Antimicrobial Pharmacotherapy ........................................................................................... 224
2i 2i 2i
Chapter 31: Antiretroviral Pharmacotherapy............................................................................................ 235
2i 2i 2i
Chapter 32: Psychopharmacology and Integrative Health: Combined Treatment ofPsychiatric and Neuroc
2i 2i 2i 2i 2i 2i 2i 2i 2i 2i
ognitive Conditions .................................................................................................................................... 247
2i
Chapter 33: Pharmacotherapy for Pain Management .............................................................................. 257
2i 2i 2i 2i 2i
Chapter 34: Substance Use Disorder III: Health Promotion and Maintenance ...................................... 267
2i 2i 2i 2i 2i 2i 2i 2i 2i
Chapter 35: Over-the-Counter Medications ............................................................................................. 283
2i 2i 2i
Chapter 36: Pharmacotherapy for Obesity ............................................................................................... 291
2i 2i 2i 2i
,Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines
2i 2i 2i 2i 2i 2i 2i 2i
MULTIPLE CHOICE 2i
• What is the primary purpose of the nursing assessment?
2i 2i 2i 2i 2i 2i 2i 2i
A. Identifying underlying pathologic conditions 2i 2i 2i
B. Assisting the physician in identifying medical conditions 2i 2i 2i 2i 2i 2i
C. Determining the patients mental status 2i 2i 2i 2i
D. Exploring patient responses to health problems 2i 2i 2i 2i 2i
ANS: D 2i
A nursing assessment is done to identify the patients response to health pr
2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i
oblems. During the nursing assessment phase, a comprehensive informatio
2i 2i 2i 2i 2i 2i 2i 2i
n base is developed through a physical examination, nursing history, medi
2i 2i 2i 2i 2i 2i 2i 2i 2i 2i
cation history, and professional observation. Identifying underlying pathol
2i 2i 2i 2i 2i 2i 2i
ogic conditions and assisting the physician in identifying medical conditio
2i 2i 2i 2i 2i 2i 2i 2i 2i
ns is not part of the nursing process. Determining the patients mental stat
2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i
us is one part of the nursing assessment, but it is not the primary purp
2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i
ose.
DIF: Cognitive Level: Comprehension
2i 2i 2i 2
REF: dm 36 OBJ: 1 | 3 TOP: Nursing
i 2i 2i 2i 2i 2i 2i 2i 2i 2i
Process Step: Assessment 2i 2i
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
2i 2i 2i 2i 2i 2i 2i 2i
• What is the basis of the NANDA I taxonomy?
2i 2i 2i 2i 2i 2i 2i 2 i
A. Functional health patterns 2i 2i
B. Human response patterns 2i 2i
C. Basic human needs 2i 2i
D. Pathophysiologic needs 2i
ANS: B 2i
The NANDA I taxonomy identifies human response patterns. Func
2 i 2 i 2 i 2 i 2 i 2 i 2 i 2i
tional components of health patterns are limited to activity, fluid volume,
2i 2i 2i 2i 2i 2i 2i 2i 2i 2i
nutrition, self care, and sensory perception. Basic human needs comprise
2i 2i 2i 2i 2i 2i 2i 2i 2i 2i
less than merely health patterns. Pathophysiologic needs are not part o
2i 2i 2i 2i 2i 2i 2i 2i 2 i 2i 2i
f the scope of NANDA I.
2i 2i 2i 2i 2i
, DIF: Cognitive Level: Knowledge RE
2i 2i 2i 2i
F: pp. 37-38 OBJ: 5 TOP:
2i 2i 2i 2i 2i
Nursing Process Step: Diagnosis2i 2i 2i
MSC: NCLEX Client Needs Category: Physiological Integrity
2i 2i 2i 2i 2i 2i
• Which task is included in the assessment step of the nursing process?
2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i
A. Establishing patient goals/outcomes 2i 2i
B. Implementing the nursing care plan (NCP) 2i 2i 2i 2i 2i
C. Measuring goal/outcome achievement 2i 2i
D. Collecting and communicating data 2i 2i 2i
ANS: D 2i
Data are collected and communicated in the assessment phase of the nursi
2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i
ng process. Establishing goals is the function of planning.
2i 2i 2i 2i 2i 2i 2i 2i
Implementing the NCP is the function of implementation. Measuring outc
2i 2i 2i 2i 2i 2i 2i 2i 2i
ome achievement is the function of evaluation.
2i 2i 2i 2i 2i 2i
DIF: Cognitive Level: Comprehension
2i 2i 2i 2
REF: dm 36 OBJ: 2 | 3 TOP: Nursing
i 2i 2i 2i 2i 2i 2i 2i 2i 2i
Process Step: Assessment 2i 2i
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
2i 2i 2i 2i 2i 2i 2i 2i
• Which statement regarding nursing diagnoses is accurate?
2i 2i 2i 2i 2i 2i
a. Nursing diagnoses remain the same for as long as the disease is present.
2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i
b. Nursing diagnoses are written to identify disease states.
2i 2i 2i 2i 2i 2i 2i
c. Nursing diagnoses describe patient problems that nurses treat.
2i 2i 2i 2i 2i 2i 2i
d. Nursing diagnoses identify causes related to illness.2i 2i 2i 2i 2i 2i
ANS: C 2i
Diagnostic statements identify problems a nurse is independently able to t
2i 2i 2i 2i 2i 2i 2i 2i 2i 2i
reat within the scope of professional practice. Nursing diagnoses vary wit
2i 2i 2i 2i 2i 2i 2i 2i 2i 2i
h the changing condition of the patient. The response patterns are unique
2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i
to the patient and are not disease specific. Nursing diagnoses describe the
2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2
patients human response pattern.
i 2i 2i 2i
DIF: Cognitive Level: Comprehension
2i 2i 2i
2i
Advanced Pharmacology for Prescribers 1st Edition Luu Kayingo Latest
2i 2i 2i 2i 2i 2i 2i 2i 2i
Edition, 2024
2i
, Table of Contents 2i 2i
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines ............................................ 3
2i 2i 2i 2i 2i 2i 2i 2i
Chapter 2: Pharmacokinetics /Chapter3: Pharmacodynamics ................................................................... 13
2i 2i 2i 2i
Chapter4: Pharmacogenetics and Pharmacogenomics................................................................................ 25
2i 2i 2i
Chapter 5: Pharmacology Across the Life Span ........................................................................................ 30
2i 2i 2i 2i 2i 2i
Chapter 6: Drug-Therapy Prescribing in Special Populations ................................................................... 36
2i 2i 2i 2i 2i 2i
Chapter 7: Drug Development and Approval ............................................................................................ 45
2i 2i 2i 2i 2i
Chapter 8-Chapter 10: Foundations of Prescription Writing Chapter 9: ResponsibleControlled-
2i 2i 2i 2i 2i 2i 2i 2i 2i
Substance Prescribing Chapter 10: Antibiotic Stewardship ........................................................................ 51
2i 2i 2i 2i 2i
Chapter 11: Applied Calculations for Prescribing ..................................................................................... 58
2i 2i 2i 2i 2i
Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-
2i 2i 2i 2i 2i 2i 2i 2i 2i
Focused Prescribing Chapter 13: Pharmacotherapy for Ear, Nose, Mouth, andThroat Conditions /Chapter
2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2
14: Pharmacotherapy for Eye Conditions ................................................................................................... 67
i 2i 2i 2i 2i
Chapter 15: Pharmacotherapy for Skin Conditions ................................................................................... 74
2i 2i 2i 2i 2i
Chapter 16: Pharmacotherapy for Neurologic Conditions ........................................................................ 81
2i 2i 2i 2i 2i
Chapter 17: Pharmacotherapy for Cardiovascular Conditions.................................................................. 94
2i 2i 2i 2i 2i
Chapter 18: Pharmacotherapy for Respiratory Conditions ..................................................................... 106
2i 2i 2i 2i 2i
Chapter 19: Pharmacotherapy for Gastrointestinal Conditions and Conditions RequiringNutritional Suppo
2i 2i 2i 2i 2i 2i 2i 2i 2i
rt ................................................................................................................................................................ 117
Chapter 20: Pharmacotherapy for Genitourinary Conditions .................................................................. 128
2i 2i 2i 2i 2i
Chapter 21: Pharmacotherapy for Renal, Acid–Base, Fluid, and Electrolyte Disorders ........................ 133
2i 2i 2i 2i 2i 2i 2i 2i 2i
Chapter 22: Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions ............................. 146
2i 2i 2i 2i 2i 2i 2i
Chapter 23: Therapeutic Applications of Immunology and Vaccines ................................................... 158
2i 2i 2i 2i 2i 2i 2i
Chapter 24: Pharmacotherapy for Endocrine Disorders .......................................................................... 163
2i 2i 2i 2i 2i
Chapter 25: Pharmacotherapy for Hematologic Disorders ...................................................................... 174
2i 2i 2i 2i 2i
Chapter 26: Hematology/Oncology and Supportive Care for the Nononcologist .................................. 190
2i 2i 2i 2i 2i 2i 2i 2i
Chapter 27: Pharmacotherapy Related to Women’s Health Conditions ................................................ 196
2i 2i 2i 2i 2i 2i 2i
Chapter 28: Pharmacotherapy Related to Men’s Health Conditions ...................................................... 211
2i 2i 2i 2i 2i 2i 2i
Chapter 29: Pharmacotherapy Related to Transgender Care .................................................................. 217
2i 2i 2i 2i 2i 2i
Chapter 30: Antimicrobial Pharmacotherapy ........................................................................................... 224
2i 2i 2i
Chapter 31: Antiretroviral Pharmacotherapy............................................................................................ 235
2i 2i 2i
Chapter 32: Psychopharmacology and Integrative Health: Combined Treatment ofPsychiatric and Neuroc
2i 2i 2i 2i 2i 2i 2i 2i 2i 2i
ognitive Conditions .................................................................................................................................... 247
2i
Chapter 33: Pharmacotherapy for Pain Management .............................................................................. 257
2i 2i 2i 2i 2i
Chapter 34: Substance Use Disorder III: Health Promotion and Maintenance ...................................... 267
2i 2i 2i 2i 2i 2i 2i 2i 2i
Chapter 35: Over-the-Counter Medications ............................................................................................. 283
2i 2i 2i
Chapter 36: Pharmacotherapy for Obesity ............................................................................................... 291
2i 2i 2i 2i
,Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines
2i 2i 2i 2i 2i 2i 2i 2i
MULTIPLE CHOICE 2i
• What is the primary purpose of the nursing assessment?
2i 2i 2i 2i 2i 2i 2i 2i
A. Identifying underlying pathologic conditions 2i 2i 2i
B. Assisting the physician in identifying medical conditions 2i 2i 2i 2i 2i 2i
C. Determining the patients mental status 2i 2i 2i 2i
D. Exploring patient responses to health problems 2i 2i 2i 2i 2i
ANS: D 2i
A nursing assessment is done to identify the patients response to health pr
2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i
oblems. During the nursing assessment phase, a comprehensive informatio
2i 2i 2i 2i 2i 2i 2i 2i
n base is developed through a physical examination, nursing history, medi
2i 2i 2i 2i 2i 2i 2i 2i 2i 2i
cation history, and professional observation. Identifying underlying pathol
2i 2i 2i 2i 2i 2i 2i
ogic conditions and assisting the physician in identifying medical conditio
2i 2i 2i 2i 2i 2i 2i 2i 2i
ns is not part of the nursing process. Determining the patients mental stat
2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i
us is one part of the nursing assessment, but it is not the primary purp
2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i
ose.
DIF: Cognitive Level: Comprehension
2i 2i 2i 2
REF: dm 36 OBJ: 1 | 3 TOP: Nursing
i 2i 2i 2i 2i 2i 2i 2i 2i 2i
Process Step: Assessment 2i 2i
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
2i 2i 2i 2i 2i 2i 2i 2i
• What is the basis of the NANDA I taxonomy?
2i 2i 2i 2i 2i 2i 2i 2 i
A. Functional health patterns 2i 2i
B. Human response patterns 2i 2i
C. Basic human needs 2i 2i
D. Pathophysiologic needs 2i
ANS: B 2i
The NANDA I taxonomy identifies human response patterns. Func
2 i 2 i 2 i 2 i 2 i 2 i 2 i 2i
tional components of health patterns are limited to activity, fluid volume,
2i 2i 2i 2i 2i 2i 2i 2i 2i 2i
nutrition, self care, and sensory perception. Basic human needs comprise
2i 2i 2i 2i 2i 2i 2i 2i 2i 2i
less than merely health patterns. Pathophysiologic needs are not part o
2i 2i 2i 2i 2i 2i 2i 2i 2 i 2i 2i
f the scope of NANDA I.
2i 2i 2i 2i 2i
, DIF: Cognitive Level: Knowledge RE
2i 2i 2i 2i
F: pp. 37-38 OBJ: 5 TOP:
2i 2i 2i 2i 2i
Nursing Process Step: Diagnosis2i 2i 2i
MSC: NCLEX Client Needs Category: Physiological Integrity
2i 2i 2i 2i 2i 2i
• Which task is included in the assessment step of the nursing process?
2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i
A. Establishing patient goals/outcomes 2i 2i
B. Implementing the nursing care plan (NCP) 2i 2i 2i 2i 2i
C. Measuring goal/outcome achievement 2i 2i
D. Collecting and communicating data 2i 2i 2i
ANS: D 2i
Data are collected and communicated in the assessment phase of the nursi
2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i
ng process. Establishing goals is the function of planning.
2i 2i 2i 2i 2i 2i 2i 2i
Implementing the NCP is the function of implementation. Measuring outc
2i 2i 2i 2i 2i 2i 2i 2i 2i
ome achievement is the function of evaluation.
2i 2i 2i 2i 2i 2i
DIF: Cognitive Level: Comprehension
2i 2i 2i 2
REF: dm 36 OBJ: 2 | 3 TOP: Nursing
i 2i 2i 2i 2i 2i 2i 2i 2i 2i
Process Step: Assessment 2i 2i
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
2i 2i 2i 2i 2i 2i 2i 2i
• Which statement regarding nursing diagnoses is accurate?
2i 2i 2i 2i 2i 2i
a. Nursing diagnoses remain the same for as long as the disease is present.
2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i
b. Nursing diagnoses are written to identify disease states.
2i 2i 2i 2i 2i 2i 2i
c. Nursing diagnoses describe patient problems that nurses treat.
2i 2i 2i 2i 2i 2i 2i
d. Nursing diagnoses identify causes related to illness.2i 2i 2i 2i 2i 2i
ANS: C 2i
Diagnostic statements identify problems a nurse is independently able to t
2i 2i 2i 2i 2i 2i 2i 2i 2i 2i
reat within the scope of professional practice. Nursing diagnoses vary wit
2i 2i 2i 2i 2i 2i 2i 2i 2i 2i
h the changing condition of the patient. The response patterns are unique
2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i
to the patient and are not disease specific. Nursing diagnoses describe the
2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2i 2
patients human response pattern.
i 2i 2i 2i
DIF: Cognitive Level: Comprehension
2i 2i 2i
